Polyarteritis nodosa: Difference between revisions

(Text replacement - " ==" to "==")
 
(13 intermediate revisions by 4 users not shown)
Line 1: Line 1:
==Background==
==Background==
*Necrotizing vasculitis of small- and medium-sized blood vessels
*Necrotizing [[vasculitis]] of small- and medium-sized blood vessels
*Skin, musculoskeletal, CNS, and GI tract (spares lung)
*Skin, musculoskeletal, CNS, and GI tract (spares lung)
*Predilection to arterial bifurcations and branch sites
*Predilection to arterial bifurcations and branch sites
*Microaneurysm, thrombosis, emboli, organic ischemia, and infarction
*Microaneurysm, [[thromboembolism|thrombosis, emboli]], organ ischemia, and infarction
*Etiology: Idiopathic, HBV, HCV, hairy cell leukemia
*Etiology: Idiopathic, [[HBV]], [[hepatitis C|HCV]], hairy cell [[leukemia]]


==Diagnosis==
{{Primary Vasculitis DDX}}
===Clinical Features===
 
*Cutaneous lesion + adult onset HTN
==Clinical Features==
[[File:PMC3505767 ad-24-383-g005.png|thumb|Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.]]
*Cutaneous [[rash|lesion]] + adult onset [[hypertension]]
*Men > women (2:1)
*Men > women (2:1)
*Peak age 40-60s
*Peak age 40-60s
*Systemic: Fatigue, weight loss, weakness, fever, arthralgia
*Systemic: Fatigue, weight loss, weakness, [[fever]], [[arthralgia]]
*Cutaneous lesions (1/3 patients)
*Cutaneous lesions (1/3 patients)
**Tender erythematous nodules
**Tender erythematous nodules
**Palpable pupura (fingers, ankles, malleoli, pretibial)
**Palpable [[purpura]] (fingers, ankles, malleoli, pretibial)
**Digital cyanosis
**Digital cyanosis
**Splinter hemorrhages
**Splinter hemorrhages
**Livedo reticularis
**Livedo reticularis
*Renovascular arteritis → HTN
*Renovascular arteritis → [[hypertension]]
*Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
*Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
*Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
*Mesenteric vasculitis (abdominal angina, [[mesenteric ischemia|ischemia]], infarction, perforation)
*Myocardial ischemia and heart failure
*[[Myocardial ischemia]] and [[heart failure]]
*Myalgia (elevated CK)
*[[Myalgia]] (elevated CK)


===Classification===
==Differential Diagnosis==
*American College of Rheumatology 10 criteria (at least 3, has 82% sensitivity and 87% specificity)
*Embolism, thrombosis, atherosclerosis
**Unexplained weight loss greater than 4kg
*[[HIV]], [[Hepatitis]], IE, [[mycotic aneurysm]]
**Livedo reticularis
*Fibromuscular dysplasia
**Testicular pain or tenderness
*Microscopic polyangiitis, [[Granulomatosis with polyangiitis]] (Wegener's), [[Eosinophilic granulomatosis with polyangiitis]] (Churg-Strauss), IgA vasculitis, drug-induced vasculitis, [[connective tissue disease]], [[SLE]], cryoglobulinemic vasculitis
**Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
**Mononeuropathy or polyneuropathy
**New-onset diastolic blood pressure > 90mmHg
**Elevated serum BUN (>40mg/dL or 14.3mmol/L) or Cr (>1.5mg/dL or 132 mmol/L)
**Evidence of HBV infection (serology)
**Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
**Biopsy of small- or medium-sized artery containing polymorphonuclear cells


==Workup==
==Evaluation==
===Workup===
*Definitive: Tissue biopsy
*Definitive: Tissue biopsy
*Labs:
*Labs:
**Cr, CK, LFT (elevated)
**Cr, CK, [[LFTs]] (elevated)
**CBC (Leukocytosis, normochromic anemia, thrombocytosis)
**CBC ([[Leukocytosis]], normochromic [[anemia]], [[thrombocytosis]])
**Hepatitis serology
**[[viral hepatitis|Hepatitis serology]]
**UA (proteinuria)
**[[Urinalysis]] ([[proteinuria]])
**ESR/CRP
**ESR/CRP
*Imaging
*Imaging
Line 49: Line 45:
**Arteriograms  
**Arteriograms  
**CT/MRI
**CT/MRI
*To consider: CXR, blood cx, autoimmune serologic testing (ANCA, ANA, RF) to r/o other diseases
*Consider: [[CXR]], blood cultures, autoimmune serologic testing (ANCA, ANA, RF) to rule out other diseases


==Differential Diagnosis==
===Diagnosis===
*Embolism, thrombosis, atherosclerosis
====American College of Rheumatology Criteria====
*[[HIV]], [[Hepatitis]], IE, mycotic aneurysm
''Need at least 3/10 (82% sensitivity and 87% specificity)''
*Fibromuscular dysplagia
*Unexplained weight loss greater than 4kg
*Microscopic polyangiitis, Wegener's, Chug-Strauss, IgA vasculitis, drug-induced vasculitis, connective tissue disease, SLE, cryoglobulinemic vasculitis
*Livedo reticularis
*[[Testicular Pain]] or tenderness
*Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
*Mononeuropathy or polyneuropathy
*New-onset diastolic blood pressure > 90mmHg
*Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
*Evidence of HBV infection (serology)
*Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
*Biopsy of small- or medium-sized artery containing polymorphonuclear cells


==Management==
==Management==
*Rheumatology consult
*Rheumatology consult
*May warrant surgical intervention if abdominal involvement
*May warrant surgical intervention if abdominal involvement
*Corticosteroid:  
*[[Corticosteroids]]:  
**[[Prednisone]] 1mg/kg  
**[[Prednisone]] 1mg/kg  
**[[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening
**[[Methylprednisolone]] (7-15mg/kg, max 1000mg IV) for severe, organ threatening
*Immunosuppressive agent for moderate to severe
*Immunosuppressive agent for moderate to severe
**Cyclophosphamide (600mg/m2<sup>) q2weeks x 3 doses
**[[Cyclophosphamide]] (600mg/m2<sup>) q2weeks x 3 doses
*ACEI or ARB for HTN
*[[ACEI]] or [[ARB]] for hypertension


==References==
==References==
Line 75: Line 79:


[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Vascular]]

Latest revision as of 17:35, 2 August 2023

Background

  • Necrotizing vasculitis of small- and medium-sized blood vessels
  • Skin, musculoskeletal, CNS, and GI tract (spares lung)
  • Predilection to arterial bifurcations and branch sites
  • Microaneurysm, thrombosis, emboli, organ ischemia, and infarction
  • Etiology: Idiopathic, HBV, HCV, hairy cell leukemia

Vasculitis Syndrome Types

Clinical Features

Cutaneous polyarteritis nodosa. (A) The patient presented with livedo reticularis on the lower legs. (B) Vasculitis involves the muscular artery of the deep dermis.
  • Cutaneous lesion + adult onset hypertension
  • Men > women (2:1)
  • Peak age 40-60s
  • Systemic: Fatigue, weight loss, weakness, fever, arthralgia
  • Cutaneous lesions (1/3 patients)
    • Tender erythematous nodules
    • Palpable purpura (fingers, ankles, malleoli, pretibial)
    • Digital cyanosis
    • Splinter hemorrhages
    • Livedo reticularis
  • Renovascular arteritis → hypertension
  • Peripheral neuropathies (mononeuritis multiplex, polyneuropathy)
  • Mesenteric vasculitis (abdominal angina, ischemia, infarction, perforation)
  • Myocardial ischemia and heart failure
  • Myalgia (elevated CK)

Differential Diagnosis

Evaluation

Workup

Diagnosis

American College of Rheumatology Criteria

Need at least 3/10 (82% sensitivity and 87% specificity)

  • Unexplained weight loss greater than 4kg
  • Livedo reticularis
  • Testicular Pain or tenderness
  • Myalgia (excluding shoulder and hip girdle), weakness of muscles, tenderness of leg muscles, or polyneuropathy
  • Mononeuropathy or polyneuropathy
  • New-onset diastolic blood pressure > 90mmHg
  • Elevated serum BUN (>40mg/dL or 14.3mmol/L) or creatinine (>1.5mg/dL or 132 mmol/L)
  • Evidence of HBV infection (serology)
  • Characteristic arteriographic abnormalities not resulting fro noninflammatory disease processes
  • Biopsy of small- or medium-sized artery containing polymorphonuclear cells

Management

References

  • Reference: Rosen's Emergency Medicine 8th edition. 2013. Chapter: Erythematosus and the Vasculitides. p1539-1540.
  • Merkel PA, et al. Clinical manifestations and diagnosis of polyarteritis nodosa in adults. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Merkel PA, et al. Treatment and prognosis of polyarteritis nodosa. In: Post T, ed. UpToDate. Waltham, Mass.: UpToDate; 2014. www.uptodate.com. Accessed December 22, 2014.
  • Jacobs-Kosmin, D. (2014, Dec 12). Polyarteritis Nodosa. eMedicine. Retrieved 12/22/2014 from http://emedicine.medscape.com/article/330717-overview.